Overseas Exhibition Preview | Nanodigmbio Looks Forward to Meeting You at ESHG Gothenburg, Sweden

01 · About ESHG2026 ·

The 2026 Annual Conference of the European Society of Human Genetics (ESHG) will take place from June 13 to 16 at Svenska Mässan Exhibition & Congress Centre, Gothenburg, Sweden.

Regarded as one of the most authoritative and influential top academic events in the field of human genetics worldwide, this conference will bring together more than 3,000 distinguished experts, researchers and industrial delegates across the globe to explore the latest development of the discipline.

The agenda covers a wide range of frontier themes, including Reproductive and Prenatal Genetics, Cancer Genetics, Neurodegenerative Diseases, Multi-omics and Bioinformatics, as well as novel genetic diagnostic technologies. A concurrent technology exhibition will showcase innovative products and comprehensive solutions in gene sequencing, precision genetic testing and bioinformatics data analysis.

ESHG aims to build a high-end platform for academic exchange, technical communication and industrial cooperation, facilitating the integration of fundamental research and clinical practice in human genetics, and driving high-quality innovation and industrialization of global precision medicine.

02 · Nanodigmbio TIME ·

Exhition Info

【Date】13^th-16^th June, 2026

【Avenue】Svenska Mässan, Mässans Gata/Korsvägen

【Location】Hall B, Booth NO.638

Invitation

We warmly invite all industry partners, clinicians, medical representatives, and scientific researchers to visit Booth 638. We look forward to face-to-face communications with you

We look forward to meeting and interacting with you on-site.！

Product features

1. Whole Exome Sequencing | NEXome-series Panel 

Nanodigmbio has launched 4  products for different application scenarios, forming the NEXome series Panel based on NEXome Core Panel. These products differ from one another in terms of coverage regions, variant detection, and other aspects, allowing users to select according to their needs。

• NEXome Core Panel On the basic of the version of Refseq (109, 2021) and the CCDS database, NEXome Core Panel has carefully selected some regions that are worthy of attention outside the database. At the same time, based on product continuity considerations, some regions deleted in the latest version of the database have been retained. The NEXome Core Panel contains approximately 400,000 single-stranded DNA probes by independently synthesized and independently inspected for quality, targeting a 34.7Mb genomic region (19,613 genes). NEXome Core Panel, as a core all-exome Panel which can be combined with different spike-in panels to meet different application requirements.。

• NEXome Plus Panel v1.0 is an enhanced whole-exome capture panel covering approximately 43.3 Mb of the human genome, making it more suitable for cancer diagnostics.

• NEXome XP Panel v1.0 is an enhanced, extended whole-exome capture panel covering approximately 45.9 Mb of the human genome, making it more suitable for genetic diagnostics.

• NEXome Mini Panel v1.0 focuses on disease-relevant regions within the whole exome and is associated with more than 4,000 genetic disorders. Compared with a comprehensive whole-exome panel, NEXome Mini Panel v1.0 enables faster and more efficient detection of pathogenic variants in target genes across the human genome. By concentrating sequencing efforts on clinically relevant regions, it not only reduces sequencing costs but also significantly shortens duration of data analysis.

2. Newborn Genetic Screening | NBGS Premium Panel v1.0  

NBGS Premium Panel v1.0 is a targeted capture-based newborn genetic screening panel covering 311 clinically significant and actionable hereditary disorders across 282 disease-associated genes. It supports simultaneous detection of SNPs, InDels, and CNVs within a single assay. Featuring an SNP-enriched probe design, the panel delivers enhanced sensitivity for exonic and intronic CNV detection and includes optimized coverage of key pathogenic gene regions. Coupled with a fully integrated visualized bioinformatics platform, NBGS Premium Panel v1.0 streamlines the workflow from sample processing to automated report generation, enabling efficient, accurate, and scalable newborn genetic screening.

Nanodigmbio offers three customizable newborn screening sub-panels—Mini, Core, and Plus—to meet the needs of different regions and populations with flexible configuration and rapid implementation. Validated across two sequencing platforms and reference standards, NBGS Premium Panel v1.0 demonstrated consistent performance in on-target rate, target coverage, and variant detection. High concordance with expected results in DMD and thalassemia reference samples confirms its reliability for screening newborn genetic metabolic and multisystem disorders. The panel supports disease risk assessment and carrier identification, providing valuable support for precision medicine and early intervention.

3. Hemoglobin Gene Detection | HGBP Panel v1.0

HGBP Panel v1.0 targets human hemoglobin-encoding genes, nearby genomic regions, and regulatory genes. The probes cover a 160 kb genomic region, facilitating the enrichment of various variant information related to human hemoglobin.

• For the hemoglobin-encoding genes, coverage extends to the entire region within 1 kb upstream and downstream, enriching various sequence variations in both coding and non-coding regions.；

• In the areas containing gene clusters, there is dense coverage of the SNP framework to enhance the analytical capability for copy number variations across the entire region, utilizing SNP sites with high population heterozygosity；

• Known structural mutation breakpoints are covered, and known recombinations can be directly analyzed through split reads；

• Coding regions for regulatory genes (BCL11A，HBS1L，KLF1，MYB) , as well as a series of non-coding polymorphic loci (30 in total), are also covered.

In order to better complement the HGBP Panel v1.0 detection, Nanodigmbio carefully developed a one-stop bioinformatics analysis workflow specifically for thalassemia detection, namely ThalaScan. The main functionalities include detecting point mutations, InDels, and SVs in the Hb region. Additionally, it can identify pathogenic variations related to thalassemia in regulatory regions and known disease-modifying factors. 

4. DMD gene Full-length Diagnostics | DMD Research Panel v1.0 

DMD Research Panel v1.0 based on NGS targeted sequencing technology, offers high throughput, high sensitivity, and controllable costs, enabling efficient screening of deletions/duplications and point mutations across the 79 exons of the DMD genes, and providing strong support for precise clinical diagnosis. This technology is suitable for newborn screening, confirmatory testing of suspected patients, and carrier screening, facilitating early intervention and informed personalized treatment decisions. When integrated with genetic counseling, it can also help families optimize reproductive planning and provide critical data to support the development of targeted therapies, contributing to a comprehensive ecosystem for DMD-related disease diagnosis, treatment, and research.

5. NadAuto-Series End-to-End Fully automated NGS Solution 

As NGS technologies continue to gain widespread adoption, laboratories are facing an increasing demand for standardized, efficient, and highly reliable workflows. To address these needs, Nanodigmbio has launched three fully automated NGS workstations—NadAuto-16R, NadAuto-48R, and NadAuto-D4R.

These platforms support a broad range of applications, including sample aliquoting, nucleic acid extraction, DNA normalization, nucleic acid purification, quantification plate setup, sample pooling, library preparation, and hybridization capture. By significantly increasing sample-processing throughput while minimizing operator-dependent variability, the NadAuto series helps laboratories achieve greater efficiency and consistency.

The workstation features built-in dedicated run scripts, a complete set of consumables, and a pre-loaded plate-based reagent system customized exclusively for the NadAuto series, significantly simplifying manual operation steps and effectively ensuring the stability of automated experimental workflows, consistency of results, and high reproducibility of data.